India
· Delayed Price · Currency is INR NSE:HCG Statistics
Total Valuation
NSE:HCG has a market cap or net worth of INR 69.25 billion. The enterprise value is 82.36 billion.
| Market Cap | 69.25B |
| Enterprise Value | 82.36B |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:HCG has 139.35 million shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 139.35M |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +1.35% |
| Owned by Insiders (%) | 13.80% |
| Owned by Institutions (%) | 15.96% |
| Float | 35.98M |
Valuation Ratios
The trailing PE ratio is 120.99 and the forward PE ratio is 73.01. NSE:HCG's PEG ratio is 1.46.
| PE Ratio | 120.99 |
| Forward PE | 73.01 |
| PS Ratio | 3.25 |
| PB Ratio | 8.04 |
| P/TBV Ratio | 11.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.46 |
Enterprise Valuation
| EV / Earnings | 141.22 |
| EV / Sales | 3.86 |
| EV / EBITDA | 23.40 |
| EV / EBIT | 46.93 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.72 |
| Debt / EBITDA | 4.44 |
| Debt / FCF | n/a |
| Interest Coverage | 1.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.07% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 3.47M |
| Profits Per Employee | 94,837 |
| Employee Count | 6,150 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.75% in the last 52 weeks. The beta is 0.30, so NSE:HCG's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +50.75% |
| 50-Day Moving Average | 503.05 |
| 200-Day Moving Average | 438.88 |
| Relative Strength Index (RSI) | 46.49 |
| Average Volume (20 Days) | 310,673 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HCG had revenue of INR 21.32 billion and earned 583.25 million in profits. Earnings per share was 4.11.
| Revenue | 21.32B |
| Gross Profit | 11.20B |
| Operating Income | 1.75B |
| Pretax Income | 715.69M |
| Net Income | 583.25M |
| EBITDA | 2.94B |
| EBIT | 1.75B |
| Earnings Per Share (EPS) | 4.11 |
Balance Sheet
The company has 2.90 billion in cash and 15.58 billion in debt, giving a net cash position of -12.68 billion or -90.98 per share.
| Cash & Cash Equivalents | 2.90B |
| Total Debt | 15.58B |
| Net Cash | -12.68B |
| Net Cash Per Share | -90.98 |
| Equity (Book Value) | 9.06B |
| Book Value Per Share | 61.80 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 52.53%, with operating and profit margins of 8.19% and 2.74%.
| Gross Margin | 52.53% |
| Operating Margin | 8.19% |
| Pretax Margin | 3.36% |
| Profit Margin | 2.74% |
| EBITDA Margin | 13.77% |
| EBIT Margin | 8.19% |
| FCF Margin | n/a |
Dividends & Yields
NSE:HCG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.53% |
| Shareholder Yield | -1.53% |
| Earnings Yield | 0.84% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |